Hospital News and Research

RSS

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a new study in Cancer Cell led by researchers at Massachusetts General Hospital.

26 Oct 2021

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by clinical trial results published in eLife.

26 Oct 2021

Mental health determinants during COVID pandemic pregnancies in the U.K.

A new study reports the determinants of the mental state of pregnant women during the pandemic within the U.K. maternity services.

26 Oct 2021

Brain fog in long COVID

A new study explores one troubling manifestation of long COVID, which is the cognitive impairment that follows clinical resolution of COVID-19.

26 Oct 2021

New education programs aim to address the gaps in public health workforce capacity

UMass Lowell has been awarded a $3 million cooperative agreement from the U.S. Department of Health and Human Services' Office of the National Coordinator for Health Information Technology to develop new undergraduate and graduate programs in public health informatics and technology, to educate diverse students for vital jobs.

26 Oct 2021

Intussusceptive angiogenesis contributes to tumor growth in metastatic malignant melanoma

For the first time, researchers at the University of Gothenburg have shown that metastases in patients with malignant melanoma gain access to the circulatory system not only through the outgrowth of new blood vessel branches, but also an alternative process in which one blood vessel divide into two parallel vessels bylongitudinal splitting.

26 Oct 2021

Safer, more effective therapies could help fight the obesity epidemic

Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized and could help fight the obesity epidemic, according to a new manuscript published in the Endocrine Society's journal, Endocrine Reviews.

26 Oct 2021

Analysis: A procedure that cost $1,775 in New York was $350 in Maryland. Here’s why.

For the past 18 months, while I was undergoing intensive physical therapy and many neurological tests after a complicated head injury, my friends would point to a silver lining: "Now you'll be able to write about your own bills." After all, I'd spent the past decade as a journalist covering the often-bankrupting cost of U.S. medical care.

26 Oct 2021

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

Interview with Seth Walk, Principal Investigator and Associate Professor, Department of Microbiology and Cell Biology, Montana State University

From Promega Corporation 26 Oct 2021

Understaffed state psychiatric facilities leave mental health patients in limbo

Many patients dealing with mental health crises are having to wait several days in an ER until a bed becomes available at one of Georgia's five state psychiatric hospitals, as public facilities nationwide feel the pinch of the pandemic.

26 Oct 2021

Researchers develop genetic risk score to predict development of alcohol-induced cirrhosis

An international research group led by the Centenary Institute has developed a world first genetic risk score (GRS) test able to identify patients at high-risk of developing alcohol-related cirrhosis.

26 Oct 2021

Post COVID-19 affects children as well as adults

A new study presents data on long covid in adults and children, which is becoming a major issue in public health planning.

26 Oct 2021

Immune response to mRNA COVID vaccines delayed in pregnant women

Researchers in the United States have conducted comprehensive profiling of humoral immune responses in pregnant, lactating, and non-pregnant women following coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccination to probe differences in vaccine-induced immunity.

25 Oct 2021

Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA

The mechanism which allows β-lactam antibiotics, including penicillin, to kill MRSA has been revealed for the first time.

25 Oct 2021

Water and surface surveillance can detect 93% of school-based COVID-19 cases

A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.

25 Oct 2021

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer.

25 Oct 2021

N501Y mutation in SARS-CoV-2 Delta variant is key to breakthrough infections

A study in the Philadelphia area found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants evolve to become more contagious and resistant to COVID-19 vaccines. In addition, depending on the sublineage, SARS-CoV-2 variants such as the Delta variant led to a three-fold increased risk for vaccine breakthrough cases.

25 Oct 2021

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Researchers from the Institute of Process Engineering\ of the Chinese Academy of Sciences, Peking University and Zhujiang Hospital of Southern Medical University have developed a ferritin (Fn)-based nanomedicine for targeted delivery of arsenic (As) and efficient therapy against diverse leukemia types.

25 Oct 2021

Researchers investigate SARS-CoV-2 specific immunity in young Swedish adults

Researchers at Karolinska Institutet in Sweden have analyzed the presence of SARS-CoV-2-specific antibodies and memory cells of the immune system in young adults.

25 Oct 2021

Genetic biomarker test predicts how men with high-risk prostate cancer will respond to treatment

A new meta-analysis finds that a genetic biomarker test accurately predicts how men with high-risk prostate cancer will respond to treatment with radiation and hormone therapy.

25 Oct 2021

Hospital News and Research

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

Mental health determinants during COVID pandemic pregnancies in the U.K.

Brain fog in long COVID

New education programs aim to address the gaps in public health workforce capacity

Intussusceptive angiogenesis contributes to tumor growth in metastatic malignant melanoma

Safer, more effective therapies could help fight the obesity epidemic

Analysis: A procedure that cost $1,775 in New York was $350 in Maryland. Here’s why.

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

Understaffed state psychiatric facilities leave mental health patients in limbo

Researchers develop genetic risk score to predict development of alcohol-induced cirrhosis

Post COVID-19 affects children as well as adults

Immune response to mRNA COVID vaccines delayed in pregnant women

Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA

Water and surface surveillance can detect 93% of school-based COVID-19 cases

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

N501Y mutation in SARS-CoV-2 Delta variant is key to breakthrough infections

Researchers develop ferritin-based nanomedicine for targeted delivery of leukemia therapy

Researchers investigate SARS-CoV-2 specific immunity in young Swedish adults

Genetic biomarker test predicts how men with high-risk prostate cancer will respond to treatment

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News